Skip to main content

Table 4 Results on the various indicators and the summary outcome

From: Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial

Indicatora Baseline T0 Follow-up T1 Treatment effect p value
Control Intervention Control Intervention
MEAN % (SD) MEAN % (SD) MEAN % (SD) MEAN % (SD) Estimate (95% CI)
1a 61.8 (27.6) 59.1 (28.6) 49.0 (30.0) 82.7 (20.4) 34.2 (12.4, 55.9) 0.017
1b 43.4 (36.0) 45.7 (37.8) 20.9 (20.9) 59.2 (33.9) 38.8 (15.0, 62.7) 0.012
2a 0 (0) 0.01 (0.02) 4.0 (7.5) 2.6 (6.3) −3.4 (−8.0, 1.2) 0.18
2b 0 (0) 0.01 (0.02) 0 (0) 1.9 (5.6) 2.1 (−1.4, 5.5) 0.28
2c 1.4 (0.4) 1.7 (0.3) 48.4 (36.7) 25.0 (35.4) −23.2 (−63.2, 16.8) 0.24
2d 27.4 (43.8) 25.6 (33.3) 31.2 (47.6) 8.2 (22.1) −21.5 (−50.9, 8.0) 0.18
2e 70.9 (35.0) 55.3 (41.1) 93.9 (12.0) 92.7 (9.2) 0.1 (−9.2, 9.3) 0.99
3 10.9 (5.9) 13.7 (4.7) 20.8 (5.1) 14.5 (19.3) −8.1 (−15.0, 1.2) 0.08
4a 25.0 (29.6) 15.0 (26.9) 20.5 (18.8) 22.5 (18.5) 5.6 (−5.6, 16.7) 0.35
4b 0 (0) 10.0 (24.2) 2.3 (7.5) 10.0 (21.1) 2.5 (−7.5, 12.4) 0.62
Primary outcome 24.1 (6.7) 22.8 (13.0) 27.9 (6.5) 31.5 (8.0) 4.2 (−0.3, 8.6) 0.10
  1. SD standard deviation
  2. aFor explanation of the indicators, see Table 1